Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00176618 · ClinicalTrials.gov registry record · NA
The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon
A NA study, sponsored by University of Medicine and Dentistry of New Jersey.
- Terminated
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00176618 is a NA study that was terminated before completion, run by University of Medicine and Dentistry of New Jersey. The registered enrollment target is 60 participants.
The verdict
NCT00176618, a NA study, was terminated before completion, sponsored by University of Medicine and Dentistry of New Jersey.
- TERMINATED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness of curcumin in reducing the number of aberrant crypt foci (ACF) in the colon.
Interventions
- DRUG sulindac
- DRUG curcumin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2004-04 |
| Est. Completion | 2007-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00176618
The ClinicalTrials.gov registry entry for NCT00176618 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Medicine and Dentistry of New Jersey, which has 88 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which sulindac is the first listed.
NCT00176618 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00176618 about?
NCT00176618 is a clinical study titled "The Effects of Curcuminoids on Aberrant Crypt Foci in the Human Colon". The purpose of this study is to determine the effectiveness of curcumin in reducing the number of aberrant crypt foci (ACF) in the colon.
What is the current status of trial NCT00176618?
This trial is currently terminated. It is a NA study. The enrollment target is 60 participants. The study started on 2004-04. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00176618?
The interventions under investigation include: sulindac (DRUG), curcumin (DRUG).
Who is sponsoring clinical trial NCT00176618?
This trial is sponsored by University of Medicine and Dentistry of New Jersey, which has 88 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.